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STRUCTURE AND MULTIMERIZATION EFFECTS OF INORGANIC 
BINDING PEPTIDES:                                      
PHAGE DISPLAY SELECTED PT BINDERS AS A CASE STUDY    
SUMMARY 
Many organisms contain organic-inorganic hybrid systems consist of protein 
inorganic interactions. These hybrid systems have excellent functions such as 
forming protective layers, supportive tissues, transferring charge and ion, developing 
some optical and mechanical properties. These excellent as well as diversified 
functions give an enormous inspiration for novel design of genetically engineered 
materials and systems for applications in biotechnology and nano-biotechnology.  
In order to control the formation and assembly of functional inorganic hybrid 
materials and systems, inorganic-binding polypeptides have a great potential to be 
used as biolinkers and molecular building blocks for controlled assembly processes. 
Polypeptides that selectively bind to a given inorganic can be identified by using 
combinatorial biology based molecular libraries such as phage display peptide 
libraries. Selected inorganic binding peptides can further be engineered by utilizing 
protein engineering tools to design second generation peptides with controllable and 
predictable affinities.  
Protein engineering tools are composed of using both genetic and chemical 
techniques to change the structure and function of a protein; therefore they provide 
unique opportunity to further tailor the inorganic binding functionalities of the 
selected peptides. Here, the main design parameters are targeting the amino acids 
which may be playing structural or functional roles, deleting or replacing them with 
alternative ones or testing the impact of molecular structure as constrained or 
nonrestricted, hydrophobic forces, electrostatics and charge, and the placement of 
hydrogen bonds, salt bridges, disulfide bonds, water or metals. 
Here, we developed engineering protocols for inorganic binding peptides displayed 
on phage using protein engineering approach. As a case study, we have studied the 
platinum binding peptide, which was identified and characterized by our group in a 
previous study. In our engineering approach, we have developed multimerization 
protocols for displayed peptides on phage through investigation of the effect of 
constrained to nonrestricted molecular structural on the second generation peptides. 
We also adapted characterization techniques as immuno-fluorescent labeling and 
ELISA analysis to investigate the binding affinities of second generation peptides. 
Our experiments demonstrated that binding affinity could be tuned up via genetic 
engineering approaches on the host organism. These protocols will be of great utility 
for optimizing length or the molecular conformation of the inorganic specific 
peptides for controllable and predictable affinities.  
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İNORGANİKLERE BAĞLANAN PEPTİTLERE YAPISAL VE ÇOKLU 
TEKRARLARIN ETKİSİ:                                         
ÖRNEK ÇALIŞMA OLARAK FAJ GÖSTERİM YOLUYLA SEÇİLMİŞ 
PLATİNYUMA BAĞLANAN PEPTİT 
ÖZET 
Bir çok organizma protein inorganik etkileşimlerinden meydana gelen organik-
inorganik hibrid sistemler içerir. Bu hibrid sistemlerin koruyucu tabakalar ve 
destekleyici dokular oluşturmak, yük ve iyon transferi yapmak, bazı optik ve 
mekanik özellikler geliştirmek gibi mükemmel fonksiyonları mevcuttur.  
Çeşitlendirilmiş mükemmel fonksiyonlara sahip bu sistemler, biyoteknoloji ve nano-
biyoteknoloji uygulamaları olan, genetik olarak değiştirilmiş materyallerin ve 
sistemlerin yeni dizaynına olanak tanır.  
İnorganiklere bağlanan polipeptitler, kontrollü birleşim oluşumlarında biyolinker ve 
moleküler yapı taşları olarak kullanılabildiklerinden dolayı, fonksiyonel inorganik 
hibrid malzeme ve sistemlerin oluşum ve düzenlenmelerinin kontrol edilmesinde 
önemli potansiyele sahiptirler. Belirli bir inorganiğe özgün olarak bağlanan 
polipeptitler, faj gösterim kütüphaneleri gibi kombinatoriyel moleküler kütüphaneler 
kullanılarak seçilebilirler. Spesifik inorganiklere bağlanabilen seçilen peptitler, 
tanıma mekanizmalarının ve optimum yapılarının araştırılması amacıyla protein 
mühendisliği teknikleri kullanılarak tekrar dizayn edilebilirler. 
Bir proteinin yapısını ve fonksiyonunu değiştirmek için genetik ve kimyasal 
tekniklerin yararlanıldığı protein mühendisliği yöntemleri; seçilen peptitlerin 
inorganiklere bağlanma fonksiyonlarını biçimlendirmede kullanılan eşsiz bir 
metoddur.. Yapısal ve fonksiyonel işlevi olan amino asitleri belirlemede kullanılan 
en önemli dizayn parametreleri, bu aminoasitlerin yapıdan çıkarılması veya 
alternatifleriyle değiştirilmesi ya da  moleküler yapının sınırlandırılması ve serbest 
bırakılmasındaki önemini test etmek, hidrofobik, elektrostatik ve yük 
etkileşimlerinin, hidrojen bağları, tuz köprüleri, disülfit bağları, su ve metallerin 
değiştirilmesinin etkilerini incelemek seklinde sıralanabilir.    
Bu çalışmada, protein mühendisliği yöntemlerini kullanarak faj gösterim yolu ile 
elde edilen inorganiklere bağlanan peptidlerin, yapısal ve fonksiyonel işlevlerinin 
tanınması ve geliştirilmesine yönelik protokoller geliştirdik. Örnek çalışma olarak, 
grubumuzda daha önce tanımlanmış ve karakterize edilmiş olan platinyuma bağlanan 
peptiti çalıstık. Kullandığımız yöntem ile, faj üzerinde gösterilen peptidlerin 
moleküler yapının sınırlandırılmış ve serbest bırakılmış durumundaki etkilerini de 
inceleyebilmek amacı ile çoklu tekrarlarını oluşturabileceğimiz ikinci jenerasyon 
peptid eldesine yönelik bir protokol geliştirdik. Elde edilen ikinci jenerasyon 
peptidlerin, bağlanma ilgilerini tanımlayabılmek icin immuno-florasan isaretleme ve 
ELİZA gibi karakterizasyon tekniklerini uyguladık. Deneylerimiz konak organizma 
üzerinde genetik mühendisliği yöntemleri ile bağlanma ilgilerinin kontrol 
edilebileceğini göstermistir. Bu protokoller, inorganiklere spesifik peptidlerin 
 xiii
uzunluk ve moleküler konformasyonlarının optimizasyonu ile bağlanma ilgilerinin 
kontrolu icin büyük fayda sağlayacaktır.  
 xiv
1. INTRODUCTION 
1.1. Biological Materials and Systems 
Proteins are abundant and imperative macromolecules of biological systems. 
Exhibiting enormous diversity of functions, they consequently perform most of the 
biological processes such as cellular structure formation, catalyzing biological 
reactions and controlling physical conditions of biomaterials. In fact, proteins 
constitute the most valuable part of tissues by serving as transporters and self- and 
co-assembly into short and long range ordered substrates [1-4]. 
Variable properties of proteins rely on the fact that they are highly specific and 
selective towards their ligands [5].  Proteins interact with other macromolecules and 
inorganics to control the structures and the functions of biological systems [3]. While 
macromolecular interactions are observed in soft tissues such as muscle, skin and etc. 
[6], macromolecular-inorganic hybrids form the basis of hard tissues [3, 7].  
Hard tissues include bones, dental tissues, shells, spicules, spines, skeletal units of 
single cell organisms or plants, bacterial thin film and nanoparticles are composed of 
at least one proteinaceous phase together with inorganic materials. Specific inorganic 
binding proteins generate proteinaceous phase bind and organize inorganic materials 
to perform protective layer formation, ion transferring and developing some optimal 
and mechanical properties. The inorganic material, on which the proteinaceous phase 
is bound, commonly include magnetite (Fe3O4) particles in magnetotactic bacteria or 
teeth of chiton [8]; silica (SiO2) as skeletons of radiolarian [9] or tiny light-gathering 
lenses and optical wave guides in sponges [10]; hydroxyapatite (Ca2C(OH)3) in 
bones [11] and dental tissues of mammals [12] and calcium carbonate (CaCO3) in the 
shells of mollusks [13]. (Figure 1.1)  
Similar properties of inorganic materials in nanometer-scale dimensions are utilized 
for nano - and biotechnological applications such as chemical, biological and optical 
sensors, spectroscopic enhancers, nanoelectronics and quantum structures. In 
contravention of great potential of nanotechnological systems, they are limited by the 
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reasons of difficulties in their synthesis and assembly into functional structures 
[3,14,15].  
 
Figure1.1 Examples of biologically synthesized complex materials a) Scanning 
electron microscope (SEM) image of a growth edge of abalone (Haliotis rufescens) 
displaying aragonite platelets (blue) separated by organic film (orange) that 
eventually becomes nacre (mother-of-pearl) (inset: transmission electron microscope 
(TEM) image) b) Magnetite nanoparticles formed by magnetotactic bacterium 
(Aquaspirillum magnetotacticum, inset: TEM image) are singlecrystalline, single-
domained, and crystallographically aligned. c) Mouse enamel (SEM image) is hard, 
wear resistant material with highly ordered micro/nano architecture consisting of 
hydroxyapatite crystallites that assemble into woven rod structure (inset: schematic 
cross-section of a human tooth) d) Sponge spicule (with a cross-shaped apex shown 
in inset) of Rosella has layered silica with excellent optical and mechanical 
properties, a biological optical fibre (SEM image). [4] 
1.2. Inorganic binding proteins 
Being inspired by nature, hybrid materials can be developed combining molecular 
biology tools with nanotechnology under the name molecular biomimetics to 
overcome difficulties faced up in nanotechnological applications. In order to control 
formation and assembly of functional inorganic hybrid materials and systems, 
inorganic-binding polypeptides are used as biolinkers and molecular building blocks 
[4,14].  
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1.2.1. How to Obtain Inorganic Binding Proteins 
Till now a few proteins have been identified to bind inorganic materials. Most known 
example of these proteins is ice-binding protein found in many fish species, plants 
and insects [16]. Just unidentified inorganic-binding proteins could be obtained in 
several ways. 
One of these ways is designing inorganic-binding proteins by using theoretical 
molecular approach [17]. However this is an impractical and expensive way to 
design inorganic-binding proteins.  
Another way is to extract and purify proteins from hard tissues and cloning the genes 
coding them [18]. Adverse consequences of this approach are that hard tissues 
contain many proteins [19] and extracted protein could only be utilized for the 
regeneration of specific inorganics, could not be used for engineering of other 
nanostructures.  
The use of combinatorial biology techniques is an emerging field in design of 
inorganic binding proteins [20]. In this approach, inorganic-binding proteins are 
selected against a specific inorganic material from combinatorial biology libraries 
[3,14]. These libraries composed of random peptides with the same number of amino 
acids but different in sequence compositions. “Phage Display” and “Cell Surface 
Display” are well-known in vitro combinatorial biology techniques [21, 22]. These 
display techniques mainly were carried out to perform the characterization of 
receptor and antibody binding sites, the study of protein-ligand interactions and the 
isolation and evolution of proteins or enzymes exhibiting improved or altered 
binding characteristics for their ligands [23] are also adapted for the selection of 
inorganic binding peptides [3,14]. 
Up to date, phage display has been employed to identify peptides that are specific to 
gallium arsenide [24], silica [25], silver [26], zinc sulfide [27], calcite [28], cadmium 
sulfide [29], and noble metals such as platinum and palladium [30]. Cell surface 
display also has been applied to identify the iron oxide [14, 31], gold [14, 32], zinc 
oxide, zeolites and cuprous oxide [33] specific binders. 
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1.2.2. Phage Display   
Phage display is an in vitro combinatorial biology technique that enables peptides 
with desired binding affinities to be selected from a large library of variants. Phage 
display, first executed by G. Smith to follow antigen-antibody recognitions [34], is 
also be used to study protein-ligand interactions and to extract engineered proteins 
with altered affinities [23].             
Phage display involves the expression of peptides on phage coat. The gene of interest 
is fused to the coat protein of phage, leading phage particle to display the encoded 
peptide and contain its gene. Thereby, a direct link is constituted between phenotype 
and genotype. This allows identifying selected colons by sequencing.  
Various vectors are used as vehicles for phage display. The first developed vehicle, 
filamentous bacteriophage M13 (Ff family), is still widely used. This is due to ease 
of manipulating phage genome and obtaining high titers (1011-12 particles per 
milliliter).  Besides these advantages, use of filamentous phage vehicles has some 
drawbacks emanated from the entrance of coat proteins to the host cell membrane. 
Whereas these limitations such as limited peptide size to be displayed are interfere 
with the properties of desired protein to be expressed, phage λ, T7 or T4 can be 
preferred [35, 36]. However there are some studies on λ, T7 or T4 phage-based 
display systems, they are not yet used in a routine way.     
1.2.2.1. Types of Phage Display Peptide Libraries 
Phage display peptide libraries are constructed via inserting the randomized peptide 
coding sequences as a fusion into coat proteins of phage particle. With different 
phage vectors, different coat proteins can be utilized as peptide displaying agents. In 
the case of M13, all five coat proteins can be used to display peptides or proteins 
[37]. 
Different M13-based phage display peptide libraries can be generated according to 
the insertion site (Table 1.1.) and length of the insert. N-terminal display has been 
achieved with minor coat proteins g7p and g9p [38], while fusions into g6p have 
been performed into C-terminal [39]. Both C- and N-terminal display have been 
demonstrated with g3p and g8p [40, 41, 42].    
 
 4
Table 1.1. M13 coat proteins are given with their amino acid length, molecular 
weights and copy numbers exist on phage particle. N and C type display indicates the 
displayed peptide fusion site on coat protein. [43] 
 
Among all five coat proteins, g3p and g8p are most widely used for generation of 
phage display libraries that are generally based on N-terminal fusions. Only short 
peptides (6-8 residues) can be displayed on every copy of major coat protein g8p. 
Larger peptides can be displayed only on 10% of the coat proteins because of the size 
restrictions of the channel through which phage pass during assembly. The minor 
coat protein g3p, present in 5 copies on phage coat, is more tolerant for large 
insertions and short peptides can be monovalent displayed without interfering with 
the phage infectivity to generate library [37]. As a result, peptides expressed as g3p 
fusions are present at low valency (1-5 copies per virion), while g8p fusions are 
present at high valency (~200 copies per virion). The increased avidity effect of high 
valency g8p display permits selection of very low affinity ligands, while low valency 
g3p display limits selection to higher affinity ligands. 
Phage libraries can also be generated in constraint form by adding two cysteine 
residues on both ends of the insert peptide (Figure 1.2). In an oxidizing environment, 
such as the E. coli. periplasm, disulfide bond is formed between cysteine residues. 
The constraint libraries are useful for targets whose native ligands are in the context 
of a surface loop, such as antibodies with structural epitopes. Additionally, imposing 
structural constraint on the unbound ligand results in less unfavorable binding 
entropy, improving the overall free energy of binding compared to unstructured 
ligands. A major disadvantage of the constraint libraries is that the disulfide 
constraint may “freeze out” a conformation required for target binding. [44, 45] 
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 Figure 1.2. Diagram of 7 amino acid long, unconstraint (linear) and constraint phage 
displayed peptides. [46]   
To sum up, libraries can be generated by inserting 5-38 amino acid long peptides but 
increasing length of peptides may affect the display efficiency and phage viability. 
Commercially available libraries are present with 7, 12 and 15 amino acid long 
insertions and both in linear and constraint form (C7C- disulfide constraint 7 amino 
acid long peptide displaying library). 
1.2.2.2. M13 Filamentous Bacteriophage 
Filamentous bacteriophages are bacterial viruses that infect many gram-negative 
bacteria. They have common characteristics that they contain a circular ssDNA 
(single stranded) genome covered with a flexible tube composed of thousands of a 
single major coat protein. “Ff” phages constitute one of filamentous phage families 
that infect E. coli. Phages f1, fd and M13 are commonly Ff phages and they are ideal 
vehicles for phage display technology [37, 43]. 
M13 is a filamentous phage with a diameter of 6 nm and a length of nearly 1μm. 
M13 phage genome consists of 6400 nucleotides that codes 10 genes as shown in 
Figure 1.3. Five of these genes encode phage coat proteins while the proteins 
encoded by the other genes take place in viral replication and assembly [37, 43]. 
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      Figure 1.3. M13 phage genome [47] 
Five coat proteins called g3p, g6p, g7p, g8p and g9p constitutes the structure of 
phage particle as shown in Figure 1.4. The hollow tube surrounding M13 genome is 
composed of ~2700 copies of g8p, major coat protein, held together by hydrophobic 
interactions. Positively charged residues of major coat protein located in the inner 
part of the particle interact with phosphates of viral ssDNA. The blunt end of phage 
particle is made up from 3-5 copies of minor coat proteins g7p and g9p. Phage 
assembly begins at the blunt end; therefore in the absence of either protein g7p or 
g9p, no phage particle is formed. The other coat minor coat proteins g3p and g6p are 
located in the pointed end of phage particle and are exist in five copies. While the 
function of g6p in phage particle is not known, g3p has an important role in host cell 
recognition and infection [37].   
g3p  DNA
g9p  
g7p  
g8p g6p  
 
 
 
 
 
 
 
        Figure 1.4. Structure of M13 bacteriophage [48] 
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The most is known about the structure and function of minor coat protein g3p. The 
largest and the complex coat protein, g3p consists of three domains. Two N-terminal 
domains namely N1 and N2 and one C-terminal domain called CT. These three 
domains are separated with two linker regions consist of a glycine-rich sequence.  
The structure of g3p is shown in Figure 1.5. [37]. 
 
Figure 1.5. Domain structure of g3p and fusion points for display. Three domains 
are shown from N- to C- terminus and three positions at which display fusions are 
commonly created are indicated [37]. 
All filamentous phages require pili on host cell surface for infection. M13 phage bind 
to F pilus, thus it can only infect the E. coli. strains containing F type pilus. Infection 
begins when the N2 domain of g3p binds to the top of an F pilus. When N2 binds to 
pilus, N1 releases from its normal interaction with N2. Upon N2 binding to pilus, N1 
domain interacts with the host cell membrane protein TolA and the pilus is retracted 
by an unknown mechanism. Pilus retraction brings phage particle closer to cell 
membrane and together with the other interactions between g3p and the bacterial 
membrane proteins TolQRA, phage DNA enters to host cell [49, 50]. The initial 
steps of infection mechanism can be seen in Figure 1.6.   
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 Figure 1.6. Initial steps of phage infection. a) phage binding on F pilus b) binding of 
N1 domain to D3 domain of TolA. [50] 
Phage single stranded DNA that exists in cell cytoplasm just prior to infection is 
known as “+ strand” and has the same polarity as the mRNA [37]. Host RNA 
polymerase generates a primer that initiates the complementary strand synthesis from 
the noncoding region IG. Starting from this primer, DNA polymerases and 
topoisomares convert phage DNA to a double stranded form called Replicative Form 
(RF) and newly synthesized strand is named as “– strand”. RF is used as template for 
phage gene expression and further replication. DNA replication is performed through 
a rolling circle mechanism in which phage protein g2p, specific-site nicking-closing 
enzyme encoded by phage gene II, acts an important role. g2p nicks the plus strand 
of RF at a specific site in noncoding region IG and DNA polymerase III synthesizes 
the new plus strand beginning from the 3’ end of nick. When a round of replication is 
completed, displaced plus strand is circularized by the closing activity of g2p (Figure 
1.7.). In the early stages of phage infection newly synthesized plus strands are 
converted to RF form because of the low concentration of ssDNA-binding protein, 
g5p. As its concentration increases, g5p binds to newly synthesized plus strands and 
avoid their conversion to RF. The interactions between g5p proteins on ssDNA 
perform the formation of a rod-like structured circular DNA. [37, 43, 47]. 
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                        Figure 1.7. DNA replication of M13 phage [47]  
The assembly and release of M13 phage particles occur in a secretory process that 
doesn’t disturb the host cell. Phage particles are assemble in the cytoplasmic 
membrane and secreted from the cell as they assembled. In the early stage of phage 
assembly, coat proteins are imbedded into bacterial inner membrane and the other 
phage proteins generate a channel through the membrane. Assembly initiates when 
g7p and g9p interact with g5p coated DNA and form the one end of the particle 
(Figure 1.8.). In the elongation stage, g5p replaced by g8p until the phage DNA 
covered totally with major coat protein. The incorporation of g3p - g6p complex at 
the terminal end of particle, terminates the assembly. The assembled phage is then 
released to the extracellular environment. [37, 43, 47] 
 
Figure 1.8. Diagram of M13 phage assembly. Coat proteins (white cylinders) are 
imbedded into inner membrane. Circular single-stranded DNA is extruded through 
the pore (yellow cylinders). [43]  
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1.3. Protein Engineering 
Protein engineering can be defined as the use of genetic and chemical techniques to 
change the structure and function of a protein, thus producing a novel product with 
specific, desired properties. The act of protein engineering deals with catalysis, 
molecular recognition, folding and stability of proteins and protein-protein 
interactions. The approach for studying these questions is to target the amino acids 
which may be playing structural or functional roles, deleting or replacing them with 
alternative ones to test the impact of constraints, hydrophobic forces, electrostatics 
and charge, and the placement of hydrogen bonds, salt bridges, disulfide bonds, 
water or metals [51, 52]. 
There are two general strategies for protein engineering. The first is known as 
rational design, in which detailed knowledge of the structure and function of the 
protein is utilized to make desired changes. This has the advantage of being generally 
inexpensive and easy. However, there is a major drawback in that detailed structural 
knowledge of a protein is often unavailable. 
The second strategy is known as random approach (directed evolution). This 
includes repeated rounds of random mutagenesis, followed by selection for the 
improved property of interest. This method mimics natural evolution and has 
advantage that require no prior structural knowledge of a protein. However, large 
amounts of recombinant DNA must be mutated and the products screened for desired 
qualities as a drawback  
1.3.1. Rational Approaches 
Rational protein design by site specific mutagenesis is a very efficient strategy to 
obtain proteins with improved features and reshape their structure and so 
specificities. These knowledge-based studies greatly benefit from the most recent 
computational analyses of protein structures and functions. The combination of 
rational and combinatorial methods opens up new vistas in the design of stable and 
efficient enzymes{references}.  
Proteins can be engineering in rational way using “site-directed” and “cassette 
mutagenesis” techniques. 
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1.3.1.1. Site Directed Mutagenesis 
Site directed mutagenesis allows one to change the gene sequence, and hence the 
amino acid sequence of an expressed protein. One important use of this method is to 
define the postulated role of specific amino acid residues because mutations can be 
placed precisely. To follow protein functions, amino acids in a specific site of protein 
can be substituted with another amino acid obtaining opposite properties. Comparing 
the binding affinity of each mutant to that of the wild type allows understanding the 
effect of mutated amino acid. [53, 54] 
A number of strategies have been developed to construct site-directed mutants in 
vitro, all depend on the ability to chemically synthesize oligonucleotides [55, 56]. 
The oligonucleotide including the desired mutation is annealed with to one strand of 
the DNA of interest and serves as primer for initiation of DNA synthesis. By this 
way one of the strands of template includes the desired mutation. In the method 
developed by Michael Smith, the mutagenic strand is synthesized complementing the 
one of the strands of parental DNA resulting with one mutant strand. The 
heteroduplex is propagated by transformation in E. coli. After propagation, in theory, 
about 50% of the produced heteroduplexes will be mutants and the other 50% will be 
the "wild type" (no mutation). [57]  
In order to increase the propagation of mutated DNA some selection and enrichment 
methods have been generated. By these methods unmutated strand can be eliminated 
by digestion or using the feasible characteristics of the host cell. Once parental DNA 
is methylated and used for mutagenesis reaction. This methylated DNA can be 
eliminated and seperated from unmethylated (mutated) DNA strand extended during 
PCR by digesting with dnpI enyme or by the cell.  Thus, the cell could amplify only 
mutand strand. 
Using site-directed mutagenesis, at least one base change can be incorporated but 
also, mutagenic primers can be designed to generate multiple substitutions, deletions 
or insertions (Figure 1.9) [58].   
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 Figure 1.9. Site-directed mutagenesis; substitutions, insertions, deletions. [58] 
1.3.1.2. Cassette Mutagenesis 
Another approach to genetic alteration is through cassette mutagenesis. Cassette 
mutagenesis is the removal of a large section “cassettes” of DNA. The original 
cassette is replaced by a second cassette that contains synthetic DNA in which one or 
more of the base pairs have been altered (Figure 1.10) [58]. 
 
Figure 1.10. Cassette replacement [58] 
It is also possible to replace the original cassette with a cassette for antibiotic 
resistance. This type of cassette mutagenesis is known as gene disruption. The 
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resulting clone will be antibiotic resistant, but will have lost the gene function where 
the insertion took place. 
In cassette mutagenesis approach, synthetic oligonucleotide is extended to obtain 
double stranded DNA and this duplex “cassette” is incorporated can be replaced with 
a specific region but also can be inserted without any replacement. This technique 
can be used to obtain fusion proteins or to fuse single codons [59] at specific sites on 
double stranded DNA.  
1.3.2. Random Approaches 
Random approach is a fast and inexpensive way of finding variants of existing 
proteins that work better than naturally occurring under specific conditions. It 
mimics natural evolution in that it depends upon the selection of fitter individuals 
from a diverse population. Directed evolution allows us to explore enzyme functions 
never required in the natural environment and for which the molecular basis is poorly 
understood [60]. This bottom-up design approach contrasts with the more 
conventional, top-down one in which proteins are tamed `rationally’ using computers 
and site specific mutagenesis.  
The frequently applied strategy comprises repeated rounds of random mutagenesis, 
starting with a given parent gene of interest. After each round, the best mutant(s) is 
(are) selected and used as parent sequence(s) in the following round of random 
mutagenesis. Typically, rather low mutation frequencies are employed to suppress 
accumulation of neutral or even deleterious mutations.  
Random mutagenesis can be performed in different ways such as “Error-prone 
PCR”, “DNA shuffling” and “Random Cassette mutagenesis”. 
1.3.2.1. Error-Prone PCR 
Random mutagenesis systems are commonly based on error-prone PCR strategy. 
Changing the buffer conditions of PCR reaction and using DNA polymerases without 
rnoldading activity yields mutations [61, 62].  
Diversify PCR mutagenesis provides control over the level of random mutation by 
independently varying the amounts of manganese and dGTP in the PCR reaction. 
The mutagenesis rate can be raised by increasing the amount of manganese in the 
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reaction. Further increases in mutation rate can be obtained by increasing the level of 
one of the dNTPs in the reaction to promote misincorporation [61]. This method 
generally provides mutation rates from 2 to 8 mutations per 1 kb. Performing a 
second round of PCR using a diluted aliquot of the primary mutagenesis reaction can 
produce higher mutation rates. 
The mutated PCR products are then cloned into an expression vector and the 
resulting mutant library can be screened for changes in protein activity. In other way, 
whole plasmid can be mutated and transformed into bacterial host to obtain the 
mutant library.   
1.3.2.2. Shuffling 
DNA shuffling, a method for in vitro recombination is developed as a technique to 
generate mutant genes that would encode proteins with improved or unique 
functionality [63, 64]. It consists of a three-step process that begins with the 
enzymatic digestion of genes, yielding smaller fragments of DNA. The small 
fragments are then allowed to randomly hybridize and are filled in to create longer 
fragments. Ultimately, any full-length, recombined genes that are recreated are 
amplified via the polymerase chain reaction. If a series of alleles or mutated genes is 
used as a starting point for DNA shuffling, the result is a library of recombined genes 
that can be translated into novel proteins, which can in turn be screened for novel 
functions.  
DNA shuffling can be applied to a single gene or within the gene families encoded 
by different species. DNA shuffling within gene families is termed as family 
shuffling and illustrated is given in figure 1.11. 
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 Figure 1.11. Schematic diagram of family shuffling [65] 
1.3.2.3. Cassette Mutagenesis 
Cassette mutagenesis is both considered in rational and random protein engineering 
approaches. All cassette mutagenesis techniques involve the synthesis of small 
double stranded DNA fragments to be ligated into a large vector. When a specific 
cassette with a known sequence is used for engineering, the approach is classified as 
rational. However, cassette mutagenesis can also be utilized for the generation of 
large mutant libraries with unknown sequences. In this manner oligonucleotides are 
synthesized with random codons that are encoding all 20 amino acids and converted 
to double stranded form to obtain the random cassette [66, 67]. Random library is 
screened to select the proteins demonstrating desired affinity.      
1.4. Example to Inorganic Binding Peptides: Platinum Binding Peptide 
The noble metal Pt (Platinum) has different properties including wavelength 
selective plasmon adsorption resonance characteristics, electrical conductivity and 
catalytic activity [68]. Thus, peptides selectively binding to Pt metal and the 
understanding of their binding properties would be very useful. Platinum and Pt-
binding peptides could be used for development of therapeutic materials, such as in 
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anti-tumor drugs, catalysis and as binding agents [69], and for controlled nucleation, 
morphogenesis, and assembly through nanobiofabrication. 
The peptides that exhibit binding properties against platinum have been selected in a 
previous study [30]. Phage display library with 7-amino acid random inserts in the 
g3p coat protein of M13 in polyvalent form was utilized to identify Pt-binders. The 
library used was constrained through disulfide linkages between two cysteine 
residues located at both ends of the peptide. Once the peptides were selected 
physicochemical properties of peptides have been calculated such as isoelectric 
points (pI), charges and hydrophilicities. Some of the selected Pt-binders and their 
physicochemical properties are given in Table 1.2. 
Table 1.2. Examples of Pt binding peptides selected from a disulfide-constraint 
phage display peptide library. Color codes of amino acids are given in Appendix E. 
Amino acid distributions in selected peptides have been calculated and relative 
abundance for each amino acid has been obtained. However, this statistical analysis 
only shows the amino acid residues could be important in Pt selectivity but not 
affinity strength. Therefore each peptide have been characterized for their binding 
affinities to Pt powder through fluorescent microscopy analysis. Selected peptides 
have been classified as strong, moderate and weak according to characterization 
experiments. To follow the distributions of amino acids in strong and weak binders, 
statistical analyses applied to characterized peptides. Obtained relative abundances 
showed that strong and weak binders have represented different amino acid 
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distributions (Figure 1.12). A comparison of strong and weak binders seem to 
indicate that polar and basic residues may play an important role in the mechanism of 
polypeptide binding to metallic Pt [30, 70]. 
 
Figure 1.12. A. shows the relative abundances (%) of all selected Pt-binding 
peptides B. shows the relative abundance in strong (gray bars) and in weak (white 
bars) only. 
1.5. Protein Engineering Approaches on Platinum Binding Peptide  
In this study, we have recently applied multiple-repeat based strategy on phage 
display-selected platinum binding peptides. The genetic engineering tools were 
utilized for the generation of multiple repeats of binding sequences to incorporate the 
structural properties of the inorganic surfaces, e.g., optimizing the length of the 
sequence or shape of the sequence to achieve the desired effect. Multiple repeating 
form of the peptide was constructed both in linear and constraint form in order to 
investigate peptide conformation on binding affinity. 
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One of the strong Pt-binding peptides, SD152 was engineered to investigate the 
structural and multimerization effect of peptides on binding. SD152 is a disulphide 
constraint 7-mer peptide with an amino acid of PTSTGQA. In the first step linear 
peptide was constructed. In the next step 2 and 3 repeat peptides was obtained in 
different structures.  
Binding affinity and specificity of multiple repeating peptides were compared with 
the original linear and constraint ones through immuno-fluorescent labeling and 
ELISA analysis. 
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2. MATERIALS AND METHODS 
2.1. Materials 
2.1.1. Bacterial Strains  
2.1.1.1. E. coli ER2738 host strain 
F´ lacIq. (lacZ)M15 proA+B+ zzf::Tn10(TetR)/fhuA2 supE thi. (lac-proAB). (hsdMS 
mcrB)5 (rk– mk– McrBC–) which is supplied within Ph.D.-C7C™ Phage Display 
Peptide Library Kit (Catalog# E8120S, NEB Inc.), was used as a host for wild type 
M13 phage. Electrocompetent cells were prepared according to Sambrook J [71].
2.1.1.2. E. coli DH5αTM-T1R host strain 
F- φ80lacZΔM15 Δ(lacZYA-argF) U169 deoR recA1 endA1 hsdR17 (rk-, mk+) 
phoA supE44 λ- thi-1 gyrA96 relA1 tonA, chemically competent cells were  
supplied with Gene-TailorTM Site-Directed Mutagenesis System (Catalog#12297-
016, Invitrogen). 
2.1.1.3. E. coli DH5α-FT host strain 
F- ö80lacZ Δ(lacZYA-argF)U169 recA1 endA1 hsdR17(rk-, mk+) phoA supE44 λ- 
thi-1 gyrA96 relA1/F’ proAB+ laclqZΔ15 Tn10 (tetR) was purchased from Invitrogen 
to be used as a host for mutated M13 phages (Catalog# 10643-013). 
2.1.2. Cloning Vectors 
2.1.2.1. M13KE Phage Vector 
M13KE is a derivative M13 phage vector containing cloning sites at the 5’ end of 
gene III for displaying of short peptides as N-terminal fusions. (See Appendix A. for 
vector map) and was purchased from New England Biolabs® (Catalog #E8101S, 
NEB Inc.). 
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2.1.2.2. pDrive Cloning Vector 
pDrive cloning vector (given in Appendix-B) was purchased from QIAGEN 
(Catalog# 231122) to be used for cloning of PCR products containing the single A 
(Adenine) overhang at each end. Adenine nucleotide was added at 3’ ends of blunt-
ended PCR products using QIAGEN A-Addition Kit (Catalog# 231994, Qiagen).  
2.1.4 Enzymes 
2.1.4.1. Restriction Enzymes  
Eag I (C↓GGCCG, NEB Inc) and Acc65 I (G↓GTACC, NEB Inc) restriction 
endonucleases and their reaction buffers were obtained from New England Biolab 
(Catalog # R0505L and Catalog # R0599L respectively). 
2.1.4.2. Platinum® Taq DNA Polymerase High Fidelity  
Platinum® Taq DNA Polymerase High Fidelity is an enzyme mixture composed of 
recombinant Taq DNA polymerase, Pyrococcus species GB-D polymerase that has 
proofreading ability, and Platinum® Taq Antibody.  Proofreading enzyme and Taq 
DNA polymerase mixture increases fidelity and allows amplification of long DNA 
templates up to 12 kb. not requiring any optimization. The Taq antibody provides a 
hot start for Taq Polymerase via inhibiting the polymerase activity that is restored 
after denaturation step, at 94oC. This automated Hot start in PCR increases 
sensitivity, specificity, and yield (Catalog # 11304-011, Invitrogen.). 
2.1.4.3. Klenow Fragment (3’ → 5’ exo-)  
Klenow Fragment (3´→5´ exo–)is a proteolytic product of DNA Polymerase I that 
retains polymerase activity but doesn’t have 5´→3´ and 3´→5´exonuclease activities 
and was used for the second strand synthesis (Catalog# M0212S, NEB Inc.). 
2.1.4.4. T4 DNA Ligase 
T4 DNA ligase was purchased from Roche (Catalog # 10 481 220 001). 
2.1.5. DNA Molecular Weight Markers  
DNA molecular weight standard markers (given in Appendix C) were obtained from 
MBI Fermentas.  
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2.1.6. Oligonuclotides 
Oligonucleotides given below were synthesised using an Applied Biosystems 308A 
DNA synthesizer by IONTEK. 
3R-SD152 5’ CATGTTTCGGCCGAACCTCCACCGCACGCCTGACC 
AGTCGAAGTAGGCGCCTGACCAGTCGAAGTAGGCGC
CTGACCAGTCGAAGTAGGACAAGCAGAGTGAGAATA
GAAAGGTACCCGGG  3’        
Extension Primer 5’ CATGCCCGGGTACCTTTCTATTCTC 3’ 
GTSD152d1C-F  5’ TTCTATTCTCACTCTGCTCCTACTTCGACTG 3’  
GTSD152d1C-R  5’ AGCAGAGTGAGAATAGAAAGGTACCACTAA 3’ 
GTSD152d2C-F  5’ TACTTCGACTGGTCAGGCGGGTGGAGGTTC 3’ 
GTSD152trd2C-R  5’ CGCCTGACCAGTCGAAGTAGGCGCCTGA 3’ 
GTSD152d1C-R  5’ CGCCTGACCAGTCGAAGTAGGACAAGCA 3’ 
GTSD152i2C-F     5’ GGTGGAGGTTCGGCCGAAACTGTTGAAAG 3’ 
GTSD152i2C-R  5’ TTTCGGCCGAACCTCCACCGCACGCCTGACCA 3’ 
M13-40 Primer  5' GTTTTCCCAGTCACGAC 3' 
M13-96 Primer  5´ CCCTCATAGTTAGCGTAACG 3´  
2.1.7. Bacterial Culture Media 
2.1.7.1. LB (Luria-Bertani) Media 
10 g tryptone (Acumedia), 5 g yeast extract (Acumedia), 5 g NaCl (Riedel-de-Haen) 
were dissolved in distilled water up to 1lt and the pH was adjusted to 7.0-7.5 with 10 
M NaOH and sterilized for 15 min. under 1.5 atm at 121°C. 
2.1.7.2. LB Agar Medium 
10 g tryptone, 5 g yeast extract, 5 g NaCl, 15 g bactoagar (Acumedia) were dissolved 
in distilled water up to 1 lt and the pH was adjusted to 7.0-7.5 with 10 M NaOH and 
sterilized by autoclaving. 
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2.1.7.3. Top Agar Medium 
10 g tryptone, 5 g yeast extract, 5 g NaCl, 1 g MgCl2.6H2O (Riedel-de-Haen), 8 g 
bactoagar were dissolved in distilled water up to 1 lt and sterilized by autoclaving. 
2.1.7.4. SOC Medium 
20 g tryptone, 5 g yeast extract, 0.5 g NaCl was dissolved in 950 ml deionized water. 
10 ml of 250 mM KCl was added and pH was adjusted to 7.0 with NaOH. Water was 
added up to 1lt and sterilized by autoclaving. Just before use, 10mM of MgCl2 and 
20mM of glucose were added.  
2.1.8. Stock Solutions 
2.1.8.1. Tetracyline Stock 
20 mg / ml of tetracycline (Sigma) was dissolved in 95 % ethanol and stored at -20°C 
in dark. 
2.1.8.2. Amphicilin Stock 
100 mg / ml ampicillin sodium salt was dissolved in deionized water, filter-sterilized 
and stored in dark at -20°C. 
2.1.8.3. Xgal / IPTG Stock 
1.25 g IPTG (Sigma) and 1 g Xgal (Fermentas) were dissolved in 25 ml DMF 
(Riedel-de-Haen). The solution was stored at –20°C in the dark. 
2.1.8.4. Glycerol Stock Solution 
80 ml glycerol (Riedel-de-Haen) and 20 ml distilled water were mixed to make 80 % 
(w / v). It was sterilized for 15 minutes under 1.5 atm at 121°C. 
2.1.8.5. MgCl2 Stock Solution 
5 mM MgCl2.6H2O was dissolved in distilled water up to 100 ml and sterilized using 
0.2 µm single use sterile syringe filter. 
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2.1.9. Buffers 
2.1.9.1. PEG/NaCl 
20 % (w/v) PEG-8000 (Sigma) and 2.5 M NaCl were dissolved in distilled water up 
to 100ml and sterilized for 15 min. under 1.5 atm at 121°C. 
2.1.9.2. PC Buffers 
500 ml of PC buffer was prepared by dissolving 55 mM KH2PO4 (Merck), 45 mM 
Na2CO3 (Merck), 200 mM NaCl in distilled water. Appropriate amount of detergent 
was added from the stock into PC buffer according to the desired detergent 
concentration (eg. 0.02%, 0.1%, 0.5%). Detergent stock was prepared by mixing 20 
% (w/v) Tween 20 (Merck) and 20% (w/v) Tween 80 (Riedelde- Haen). PC buffers 
were sterilized by using 0.2µm sterile syringe filter. 
2.1.9.3. PBS Buffer 
8 g NaCl, 0.2 g KCl, 1.44 g Na2HPO4-7H20 and 0.24 g KH2PO4 were dissolved in 1lt 
distilled water, pH 7.2 and sterilized for 15 min. under 1.5 atm at 121°C. 
2.1.9.4. Na-Ac Buffer 
3 M of Na-Ac (Riedel-de-Haen) was dissolved in 65 ml distilled water. pH was 
adjusted to 4.6 and distilled water was added up to 100 ml. 
2.1.9.5. 5 X TBE Buffer (1000ml) 
54 g. of Tris base, 27.5 g. boric acid, and 20 ml 0.5 M EDTA at pH 8.0 were 
dissolved in 1 liter deionized water and sterilized for 15 min. under 1.5 atm at 121°C. 
2.1.9.6. TE Buffer 
100 µl 1M Tris-HCl, 100 µl 100mM EDTA and 1 ml 1M NaCl  were mixed in 10 
ml of distilled  and sterilized for 15 min. under 1.5 atm at 121°C. 
2.1.10. Lab Equipment 
Lab equipments are given in Appendix D. 
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2.2. Methods 
2.2.1.Site-directed Mutagenesis 
Cysteine deletion and insertion mutagenesis reactions were achieved via site-directed 
mutagenesis approach. GeneTailor Site-Directed Mutagenesis Kit was optimized for 
phage DNA manipulations (Catalog# 12397-014, Invitrogen). This mutagenesis 
system mainly involves three steps; DNA methylation, mutagenesis PCR and 
transformation. At following subsections protocol is discussed in detail. 
2.2.1.1. DNA Methylation 
DNA cytosine methylase encoded by the dcm gene of E.coli. that modifies the 
internal cytosine residue at the C5-position on both strands within the sequence 
5'...CC(A/T)GG-3' was used for methylation of template. Methylated DNA was 
splited with the Mcr and Mrr restriction systems of host strain DH5α-T1 when 
transferred into [72]. This system leads the separation of mutated PCR product from 
unmutated template during amplification period following transformation. 
Methylation Reaction 
dsDNA    1 µl (100 ng) 
Methylation Buffer 1.6 µl 
10X SAM   1.6 µl 
DNA Methylase  1 µl (4U/µl) 
dH2O     10.8 µl 
Total volume  16 µl 
Reaction Conditions 
Incubated at 37oC for 1 hour. 
2.2.1.2. Mutagenesis PCR 
Two overlapping primers, one of which containing desired mutation were designed 
for each cysteine deletion mutagenesis. Mutagenesis reactions for cysteine deletion 
were performed one by one using the replicative form of first mutated phage as 
template for the second reaction. Mutagenesis reactions are described detail below. 
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Mutagenesis Reactions 
10X High Fidelity PCR Buffer    5 µl 
10 mM dNTP        1.5 µl 
50 mM MgSO4            1 µl 
Forward Primer (10 μM)      1.5 µl 
Reverse Primer (10 μM)      1.5 µl 
Methylated DNA       5 µl 
Platinum Taq DNA Polymerase High Fidelity 0,5 µl 
dH2O           34 µl 
Total Volume        50 µl 
Reaction conditions 
94oC  2 min. 
94oC  30 sec. 
55oC  30 sec.   20 cycles 
68oC  7.5 min. 
68oC  10 min. 
Primers, methylated templates and annealing temperatures were different for all 
reactions. 
Second cysteine deletion reaction for 3-repeat-SD152  
Template constraint 3-repeat-SD152  
Primers GTSD152trd2C-R,  GTSD152d2C-F 
Annealing Temprature 58oC  
Second cysteine deletion reaction for 3-repeat-SD152  
Template constraint 3-repeat-SD152  
Primers GTSD152d2C-R, GTSD152d2C-F 
Annealing Temprature 58oC  
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First cysteine deletion reaction for 3-repeat-SD152 and SD152 
Template 3-repeat-SD152-d2C 
Primers GTSD152d1C-R, GTSD152d1C-F 
Annealing Temprature 55oC  
Second cysteine insertion reaction for 2-repeat-SD152-d2C 
Template 2-repeat-SD152-d2C 
Primers GTSD152i2C-R, GTSD152i2C-F 
Annealing Temprature 58oC  
2.2.1.3.Transformation 
1. 50 μl vial of One Shot MAX Efficiency DH5α-T1R competent cells from –80 
ºC stock were taken and thaw on ice approximately 5-7 minutes. 
2. 2-5 μl of mutagenesis reaction was added directly into vial of cell and mixed 
by tapping gently. 
3. Tube was incubated on ice for 30 minutes. 
4. To perform heat shock, the tube was incubated in the 42ºC water bath for 
exactly 30 seconds without mixing or shaking. 
5. Vials were removed from the 42ºC water bath and covered with ice for 1 
minute. 
6. 500 µl of pre-warmed SOC medium was added to the vial and than incubated 
at 37ºC for exactly 30 minutes at 250 rpm in a shaking incubator. 
7. 50-100-150 and 200 μl transformation reactions were aliquot and were put 
each of them into 5 ml top agar including 25 μl 5 mM MgCl2 and 180 μl 
E.coli (DH5α-FT) mid-log culture. Mixed by vortexing and poured onto LB 
plates containing Xgal/IPTG-tet according to the dilution rates (50-100-150-
200 μl). 
8. After the plates has solidified, inverted and incubated at 37ºC overnight. 
The other day blue plaques were seen on the LB plate and storage plates were 
prepared with some plaques. These phages were amplified and ssDNA (single- 
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stranded) and dsDNA (double-stranded) of newly constructed phage were purified to 
use as a template for sequence analysis and next mutagenesis reaction respectively. 
2.2.2. Phage Display Peptide Construction 
An oligonucleotide is designed and annealed with extension primer purchased from 
NEB. Annealed duplex is extended. The gene product obtained is ligated into pDrive 
Cloning Vector and transformed into E. coli ER2738 competent cells and was 
sequenced in order to check if the desired gene was constructed. Plasmid DNA in 
pDrive Cloning Vector carrying the extended duplex is purified and digested to clone 
it into M13KE gIII vector with EagI and Acc65I. It is ligated into M13KE gIII 
vector. The ligation product is transformed into ER2738 E. coli cells. The each step 
was discussed in detail below. 
2.2.2.1. Synthesis of Double Stranded DNA from an Oligonucleotide 
Synthesized oligonucleotide was annealed with an extension primer and extended by 
Klenow enzyme. Reaction conditions are described below; 
• Annealing Reaction  
Oligonucleotide  1.1 µl (5 ug) 
Extension Primer 5.4 μl (5.3 ug.) 
TE buffer   43,5 μl 
Total volume  50 μl 
Reaction conditions 
Heated to 95oC and cooled slowly to 35oC in a water bath. 
• Extension Reaction 
Annealing reaction 50 μl 
10X Klenow Buffer 20 μl 
dNTP mix   40 μl 
Klenow enzyme  3 μl (10U/ μl) 
dH2O    87 μl 
Total volume  200 μl 
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Reaction conditions 
The samples were incubated for 20 min. at 45oC and 15 min. at 65oC. 
2.2.2.2. Cloning into a TA Vector 
TA cloning vectors contain a U overhang at each ends providing easy and efficient 
ligaton of PCR products with an A overhang. Unpaired A residues are added to PCR 
products during PCR reactions generated by Taq or any other non-proofreading 
Polymerases but not Klenow enzyme. In this study pDrive Cloning Vector was used 
combined with an A-Addition procedure.  
• A-Addition Reaction 
PCR product*    6 μl (65 ng.) 
5X A-Addition master mix** 2 μl 
dH2O      2 μl 
Total volume    10 μl 
* Here, PCR product indicates extended duplex coming from extension reaction. 
** QIAGEN® A-Addition Kit from Qiagen. (Catalog # 231994, Qiagen)  
Reaction conditions 
Incubated for 30 min. at 37oC.  
• Ligation Reaction 
pDrive cloning vector*** 1 μl (50 ng) 
A-Addition reaction  2 μl (13 ng) 
Ligation master mix*** 5 μl 
dH2O      3 μl 
Total volume   10 μl 
*** PCR Cloning Kit from Qiagen. (Catalog # 231122, Qiagen) 
Reaction conditions 
The samples were incubated for 30 min. at 16oC and an additional incubation was 
performed at 70oC for 10 min to stop the reaction.   
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• Preparation of Xgal/IPTG-amp plates 
50 µl Xgal/IPTG and 100 µl amphicillin were put into 50 ml liquid warm LB agar 
and it was poured onto plastic sterile petri dish. . 
• Transformation Procedure for Plasmids 
1. 10 μl ligation product was mixed with 20 μl E. coli ER2738 electrocompetent 
cells in a prechilled electroporation cuvette.  
2. Cuvette was placed into electroporator and 1800 volts of voltage was applied. 
3. 200µl SOC medium was added to the cuvette and whole mixture was 
transferred into a microfuge tube. Tube was incubated at 37°C, 200-250 rpm 
for 1 hour. 
4. After incubation, transforming mixture was spreaded onto Xgal/IPTG-amp 
LB agar plates in serial dilutions such as 50, 75, 100 and 150 μl.  
5. Plates were incubated overnight at 37°C. 
2.2.2.3. Plasmid Purification 
Following transformation, cell were incubated and then white colonies were selected 
and grown overnight in 5 ml. LB. 800 μl of this bacterial culture was mixed with 200 
μl 80% glycerol and stored at –80oC. Plasmid DNA was purified from rests 4 ml for 
sequencing and further applications by using QIAGEN Plasmid Mini Kit. (Catalog # 
12123, Qiagen). Procedure is described in detail below. 
1. 4 ml. bacterial culture was divided into two 2 ml microfuge tubes and 
centrifuged in a standard bench-top microfuge at 5 000 rpm for 15 minutes.   
2. The bacterial pellet in first tube was resuspended completely in 300 µl Buffer 
P1 and then transferred to second tube in order to combine the pellets. 
3. 300 µl Buffer P2 was added. Suspension was mixed gently by inverting the 
tube 5 times and incubated at room temperature for 5 minutes.  
4. 300 µl of chilled Buffer P3 was added. Mixture was mixed immediately but 
gently by inverting the tube 4-6 times and incubated on ice for 5 minutes. 
5. After incubation on ice, mixture was centrifuged in a microcentrifuge for 10 
minutes at 14 000 rpm. Supernatant was saved for further use. 
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6. QIAGEN-tip 20 colon was equilibrated by applying 1 ml of Buffer QBT and 
the column was allowed to empty by gravity flow. 
7. The supernatant obtained and saved in the previous step was applied to the 
QIAGEN-tip 20 column and it was allowed to enter the resin by gravity flow. 
8. QIAGEN-tip 20 was washed with 1 ml of Buffer QC for 4 times. 
9. The DNA that was bound to the column matrix was then eluted with 800 µl 
of Buffer QF to a 1.5 ml microfuge tube by gravity flow. 
10. Eluted DNA was precipitated with 560µl room temperature isopropanol. It 
was then centrifuged at 10000 rpm for 30 minutes and the supernatant was 
decanted.  
11. The DNA pellet was washed with 1 ml of room temperature 70% ethanol and 
centrifuged for 30 minutes at 10 000 rpm. Supernatant was decanted and the 
pellet was allowed to dry at room temperature. 
12. DNA pellet was redissolved in 30 μl elution buffer EB and stored at –20oC 
2.2.2.4. Plasmid DNA Sequencing 
Big dye reaction mix* 2 µl 
5X sequencing buffer* 1 µl 
Template dsDNA   1 µl (200ng) 
M13 –40 Primer   3.2 µl 
dH2O     2.8 µl 
Total volume   10 µl 
• Big dye® terminator v 3.1 cycle sequencing Kit from Applied Biosystems. 
Reaction conditions 
95oC   2’ 
95oC   10’’ 
55oC   10’’ 35 cycles 
60oC   4’ 
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Purification of PCR products  
1. 2 µl 3M pH 4.6 sodium acetate and 50 µl 95 % ethanol were mixed for each 
sample. 
2. 52 µl mixture was added into each PCR product and samples were incubated 
on ice for 30 min. 
3. After incubation, samples were centrifuged for 30 min. at 14000 rpm. 
4. Supernatant was discarded and DNA pellet was washed with 250 µl cold 
ethanol. 
5. Samples were centrifuged for 30 min. at 14000 rpm. 
6. Ethanol was discarded; incubating at 95oC evaporated all residual ethanol. 
7. DNA was dissolved in 20 µl di formamide. 
8. Samples were denatured by putting first at 95oC and then at -20oC for 5 min. 
ABI 3100 Avant (PE, Applied Biosystem, CA) automated sequencer was used for 
DNA sequencing.   
2.2.2.5. Cloning into M13KE Phage Vector 
pDrive plasmid vector was digested with restriction enzymes and desired DNA 
fragment was gel extracted. Cleaned and concentrated insert DNA was ligated into 
M13KE vector. Procedure is described in detail below. 
• Restriction Enzyme Digestion  
Digestion of M13KE 
M13KE    2 µl 
10X NEB buffer 3 2 µl 
BSA      2 µl 
EagI (10 U/µl)  1 µl  
Acc65I (10 U/µl) 1 µl  
dH2O     12 µl 
Total volume  20 µl 
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Reaction conditions 
Incubated for 3 hrs. at 37oC and then, for 15 min. at 65oC for inactivation. 
Digestion reaction was run on 1% agarose gel and DNA band belongs to digested 
vector DNA was extracted from gel.  
Digestion of pDrive 
pDrive     8 µl (18 µg.) 
10X NEB buffer 3  4 µl 
BSA      4 µl 
EagI (10 U/µl)  3 µl  
Acc65I (10 U/µl) 3 µl  
dH2O     18 µl 
Total volume  40 µl 
Reaction conditions 
Incubated for 7 hrs. at 37oC and then for 15 min. at 65oC for inactivation. 
Digestion reaction was run on 2.5% agarose gel and desired digestion product was 
extracted from gel.   
• Gel Extraction Procedure 
Using MinElute Gel Extraction Kit performed gel extraction reactions in this study 
(Catalog # 28604,Qiagen).  
1. DNA fragment was excised from agarose gel with a clean scalpel. Gel slices 
were put into microfuge tubes and their weight was calculated.  
2. A 3-gel volume of QC buffer was added to 1 volume of gel slice. (600 µl for 
100 mg gel). When gels were excised from a %2 or more concentrated gel, a 
6-gel volume of QC buffer was applied.  
3. Sample was incubated at 50oC for 10 min. by vortexing every 2 min. 
4. After the gel completely dissolved, the color of the mixture was checked. QC 
buffer contains a pH indicator and gives a yellow color at pH<7.5, the 
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optimum pH for DNA adsorption. If the color of the mixture was not yellow, 
10 µl of 3 M sodium acetate, pH5.0 was added. 
5. After the gel dissolved, 1 gel volume of room temperature isoproponal was 
added and mixed by inverting the tube several times. 
6. Sample was applied to min-elute column and centrifuged for 1 min. at 13000 
rpm. 
7. Flow-trough was discarded from collection tube. 
8. 500 µl QC buffer was applied to column and centrifuged for 1 min. at 13000 
rpm. 
9. Flow-trough was discarded from collection tube. 
10. In order to wash, 750 µl PE buffer was applied to colon centrifuged for 1 
min. at 13000 rpm. 
11. Flow-trough was discarded from collection tube and centrifuged for an 
additional 1 min. 
12. Spin colon placed in a microfuge and 10 µl EB buffer was applied to elute 
the DNA. After 1 min. incubation tube was centrifuged for 1 min. 
13. Eluted DNA can be stored at –20oC for long term. 
• Ligation into M13KE 
Insert      11.5 µl (2 µg.) mixed and incubated at 65oC for 5 min. 
M13KE    0.5 µl (50 ng.) and then cooled on ice.             
T4 DNA Ligase  2 µl 
10X Ligase buffer 2 µl 
PEG      2 µl 
dH2O     2 µl 
Total volume  20 µl 
Reaction conditions 
Incubated for 16 hrs. at 16oC and then for 15 min. at 65oC for inactivation. 
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• Transformation Procedure for M13KE 
Growing E.coli mid-log culture 
12.5 μl E.coli (ER2738 E.coli strain was used) was inoculated from overnight culture 
into 5 ml LB containing 10 μl MgCl2 and 5 μl tetracycline. The culture was 
incubated at 37oC, 225 rpm until mid-log phase (OD600 ~ 0.5).  
1. Ligation product was mixed with 40 μl E. coli ER2738 electrocompetent cells 
in a prechilled electroporation cuvette.  
2. Cuvette was placed into the electroporator and 1800 volts of voltage was 
applied. 
3. 200 µl SOC medium was added to the cuvette and whole mixture was 
transferred into a microfuge tube. Tube was incubated at 37°C, 200-250 rpm 
for 30 minutes 
4. After incubation, transforming mixture was separated in serial dilutions such 
as 50, 75, 100 and 150 μl. Meanwhile, 5ml. top agar were put in 15ml falcon 
tubes and kept warm in 50oC water bath. Each transforming dilution, 10 μl 
MgCl2, 5 μl tetracycline and 180 μl mid-log culture were put in 5ml. warm 
top agar, mixed by vortexing and poured onto Xgal/IPTG-tet LB agar plates. 
Plates incubated at room temperature until top agar set and then incubated 
overnight at 37oC. 
After incubation blue colonies were observed. 
2.2.2.6. Saving Phage Clones  
• Preparation of storage stock of phages 
1. 170 μl 0.02% PC buffer was put in each well of a 96-well elisa plate. 
2. Each phage plate observed on LB plates were picked up with a sterile pipette 
tip and put in different wells of elisa plate. 
3. Elisa plate was incubated in a 60oC incubator for 45 minutes. 
After incubation, plate was cooled in laminar flow and left at 4oC for overnight. 
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• Preparation of glycerol stock of phages 
1. 60 μl, 80% glycerol was put in each well of a 96-well elisa plate. 
2. 50 μl phage solution from storage culture was put in elisa plate wells filled 
with glycerol. 
3. Plates covered with parafilm and stored in –80oC. 
2.2.2.7. M13 single stranded DNA purification 
5 μl phage from storage culture was amplified in 3 ml mid-log bacterial culture. 
Single stranded phage DNA was purified from amplified culture for sequence 
analysis. DNA isolation was performed using QIAprep ® Spin M13 kit (Catalog # 
27704, Qiagen). The procedure is described below in detail. 
• Phage amplification  
Phage samples were infected into the host strain E. coli ER2738 and thereby 
amplified. Before the beginning of amplification period, E. coli host strain ER2738 
was cultured to reach the OD600 ~ 0.5 and then phage samples transferred bacteria 
culture. OD600 ~ 0.5 is the best phage-host strain propagation period. The incubation 
period is approximately 4.5 hours at 37ºC and 250 rpm. E. coli host strain ER2738 
used in amplification is a robust F+ strain with a rapid growth rate and is particularly 
well-suited for M13 propagation. ER2738 is a recA+ strain and the F factor of 
ER2738 contains a mini-transposon, which confers tetracycline resistance.  
• Single stranded DNA purification procedure 
1. Amplified culture was centrifuged at 5000 rpm for 15 min. at room 
temperature to settle down bacterial cell. Supernatant containing M13 
bacteriophage was transferred to a fresh reaction tube.  
2. 1/100 volume of Buffer MP was added (i.e. 10µl per 1 ml of phage 
supernatant.) to the supernatant. It was mixed by vortexing and incubated at 
room temperature for at least 2 min. to precipitate phage particles. 
3. A QIAprep spin column was placed in a 2 ml microcentrifuge tube and 700 
μl of the sample applied to the QIAprep spin column. 
4. Reaction tube was centrifuged for 15 sec. at 8000 rpm and flowthrough was 
discarded from collection tube. 
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5. The last two steps were repeated until all supernatant passed through 
QIAprep spin column.7 
6. 700 μl MLB buffer was added for M13 lysis and binding, to the QIAprep 
spin column and centrifuged for 15 sec. at 8000 rpm.  
7. Another 700 μl MLB buffer was added the QIAprep spin column and was 
incubated 1 min. at room temperature to lyse bacteriophage completely. 
QIAprep spin column was centrifuged for 15 sec. at 8000 rpm. 
8. 700 μl Buffer PE was loaded to spin colon and centrifuged for 15 sec. at 8000 
rpm for removal of residual salt. 
9. Buffer PE was discarded from collection tube and QIAprep spin column was 
centrifuged for an additional 15 sec. at 8000 rpm to remove residual buffer. 
10. QIAprep spin column was placed in a clean 1.5 ml microcentrifuge tube. 
100µl Buffer EB (10 mM Tris.Cl, pH 8.5) was added to the center of the 
column membrane to elute the DNA. Elution buffer in the QIAprep spin 
column was incubated for 10 min. at room temperature to increases the 
recovery of single-stranded DNA molecules. 
2.2.2.8. Single Stranded DNA Sequencing  
Big dye reaction mix  2 µl 
5X sequencing buffer  1 µl 
Template dsDNA   1 µl (50 ng) 
M13 –96 Primer   3.2 µl 
dH2O     2.8 µl 
Total volume   10 µl 
Reaction conditions 
95oC   4’ 
95oC   30’’ 
55oC   30’’ 35 cycles 
60oC   4’ 
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PCR products were purified via Na-Ac Ethanol purification as previously described, 
before applying the samples into ABI 3100 Avant (PE, Applied Biosystem, CA) 
automated sequencer. 
2.2.2.9. Phage Amplification And Purification 
1. 50 μl phage from glycerol stock was amplified in 50 ml mid-log bacterial 
culture. 
2. At the end of 4.5 hours of growth period, E.coli-phage culture was transferred 
to 250 ml sterile centrifuge tubes. 
3. Samples were centrifuged at 8000 rpm for 10 min. 
4. Supernatant was transferred to 250 ml sterile centrifuge tubes. 
5. PEG/NaCl was added (1:6) into supernatant to precipitate phage and it was 
left overnight at 4oC. 
6. Next day, samples were centrifuged at 8000 rpm for 20 min. 
7. Supernatant was discarded and phage pellet was resuspended with 5 ml PC 
buffer (no detergent) by shaking. 
8. Samples were centrifuged at 8000 rpm for 10 min. 
9. Supernatant was transferred to 50 ml sterile centrifuge tubes. 
10. PEG/NaCl was added (1:6) into solution and the solution was left 2 hours at 
4oC. 
11. Samples were centrifuged at 10000 rpm for 10 min. 
12. Supernatant were discarded and phage pellet was resuspented with 1 ml PC 
buffer (no detergant). 
13. Samples were centrifuged at 10000 rpm, for 10 min and supernatant were 
transferred to sterile microfuge tubes. 
14. PEG/NaCl solution was added (1:6) into the microfuge tube, vortexed 5 sec, 
and left at room temperature for10 min. 
15. Samples were centrifuged at 13500 rpm for 3 min to get the compact phage. 
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16. Supernatant was discarded and phage pellet was resuspended with 100 µl PC 
buffer (no detergent) by pipetting gently. 
17. Samples were centrifuged at 13500 rpm for 1.5 min. and stored at –20oC. 
2.2.2.10. Phage Titering 
Blue-white screening was performed for tittering purified phages that will be used 
for characterization experiments. 
1. 3 ml of LB was inoculated with 7.5 µl of ER2738 overnight culture and 
incubated at 37oC, 200-250 rpm until mid-log phase.  
2. While cells were growing; Top Agar was melted and dispensed 3 ml into 
sterile falcon tubes, one per expected phage dilution. Tubes were left at 45°C 
until ready for use.  
3. 10-fold serial dilutions of phage were prepared in PC buffer (without 
detergant); 190 µl PC buffer (without detergent) and 10 µl phage was put into 
96-well plate well A1. 180 µl PC buffer (without detergent) was put into 
wells from A2 to A12. Ten fold dilutions were made from A1 to A12 by 
taking 20 µl samples from preceding wells. 
4. When culture has reached to mid-log phase, 108 µl cultures were dispensed 
into microfuge tubes, 1 for each phage dilution.  
5. 12 µl of each dilution was added to each tube, vortexed quickly, and incubated 
at room temperature for 1–5 minutes.  
6. Each cell-phage mixture was added in one Top agar containing falcon together 
with 3µl tetracycline and 6 µl MgCl2. Vortexed quickly and poured onto pre-
warmed Xgal/IPTG-tet LB agar plates. 
7. Plates were cooled 5 minutes, inverted and incubated overnight at 37°C.  
8. Plaques counted on plates having ~102 plaques. Each number was multiplied 
by the dilution factor for that plate to get phage titer in plaque forming units 
(PFU) per 10 µl. 
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2.2.3. Characterization of Phage Display Peptides 
Binding affinity and specificity of multiple repeating peptides were compared with 
the original linear and constraint ones through immunolabeling fluorescent 
microscopy and ELISA analysis. At the beginning of the characterization 
experiments, Platinum powder was cleaned following the steps described below. 
Platinum Powder Cleaning Procedure 
1. 100 mg powder was weighed and put into preweighed 1.5ml microfuge tube. 
2. 100 µl dH2O was added into the tube. 
3. CH3OH/acetone mixture (1:1) was added into the tube and powder pellet was 
dissolved gently by pipetting. 
4. The sample was vortexed for 5-10 min. to prevent clump formation. 
5. The powder was sonicated for 20 min. in ultrasonic bath to break the clumps. 
6. Vortexed quickly for resuspention and centrifuged at 200 g for 3min. 
7. The supernatant was removed and 1ml 50 % isopropanol was added onto the 
powder. 
8. Vortexed for 5-10 min. 
9. The powder was sonicated for 20 min. in ultrasonic bath. 
10. Vortexed quickly for resuspention and centrifuged at 200 g for 3min. 
11. The supernatant was removed and 1ml 0.5 % PC buffer was added. 
12. The powder was sonicated for 60 min. 
13. Vortexed quickly for resuspention and centrifuged at 200 g for 3min. 
14. The supernatant was removed and 1ml 0.5 % PC buffer was added. 
15. 100 µl of powder solution was transferred into each sterile microfuge tube. 
During the sample was aliqouted, each time sample was vortexed to block 
powder settle down. 
16. Samples were centrifuged at 200 g for 3min. 
17. Samples were washed twice with isopropanol (1:1). 
18. Samples were washed twice with dH2O and dried under vacuum. 
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2.2.3.1. Fluorescent Microscopy Analysis 
Proper amount of cleaned Platinum powder suspension was incubated with 10µl 
phage (1011 PFU/10µl) in PC buffer containing 0.1 % detergent for overnight on a 
running cylinder to ensure binding. After attaching phage to the powder, phage 
sample was labeled according to immunolabelling procedure. Anti-M13 pIII 
monoclonal antibody (Amersham Biosciences) as a first antibody, which is specific 
to M13 gp8 protein and Alexa-Fluor conjugated secondary antibody fragments 
(Zenon Alexa, Molecular Probes Inc.) that contains fluorescence dye were incubated 
(1: 5 ratio) for 20 min. After this incubation period, 3 µl mixture was put in phage–
platinum solution and incubated for 10 min. on running cylinder to increase phage-
mixture interaction. Phage-powder-dye mixture was washed 2 times with PC buffer 
to eliminate non-specific interactions. Finally, these complexes were visualized by 
fluorescence microscopy (BX60, Olympus Corporation) at 20X magnification under 
WIB filter. Figure 2.1 shows the procedure. 
For each phage, the same procedure was applied with Palladium powder as a control 
for cross-specificity. 
 
  
                
Figure 2.1. Immunolabeling fluorescent procedure [73] 
2.2.3.2. ELISA Analysis 
Proper amount of clean Platinum powder incubated with 10µl phage (1011 PFU/10µl) 
in 190µl PBS buffer containing 2% BSA for 2 hours on a running cylinder to ensure 
binding. After incubation period, phage-powder mix was washed 3 times with 200µl 
PBS buffer containing 0.05% detergent. 200µl PBS buffer containing 2%BSA was 
added on washed phage-powder mix and incubated with 0.4µl HRP-AntiM13 
antibody for 30 min. by rotating. After incubation period, 4 times washing step was 
performed to send away unbound antibody from solution and than phage-powder-
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antibody conjugate suspended in 200µl PBS buffer containing 0.05% detergent. 
Enzymatic reaction was started when 100µl TMP (1-step TMP-ELISA, Catalog# 
34022, Pierce) was added into solution. Reaction was ended when the color of the 
solution turned to blue with 100µl 1M H2SO4. Colorful supernatant was measured at 
450nm.    
      Figure 2.2. ELISA protocol [73] 
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3. RESULTS AND DISCUSSION 
Linear peptide fragments are known to be flexible and exhibit numerous 
conformations in solution and even in the solid state. However, if one can restrict the 
conformational freedom of these linear peptides by introducing some constraints in 
the structure, it may render a biologically active and / or more specific peptide. 
Constraint form of peptides provides less unfavorable binding entropy, improving the 
overall free energy of binding compared to unstructured ligands. Disulphide 
constraint is one of the commonly structures in peptide libraries for the selection of 
the short peptides for desired targets. [44, 45] 
Peptides displayed on phage libraries are generally composed of 7-12 amino acids. 
These kinds of short peptides can get multiple conformations however; this can result 
reducing the conformation of active forms. Multimerization of short peptides could 
change their properties, leading in a more rigid structure especially important in the 
controlled assembly processes. The increased number of binding sites in repeating 
peptides may provides an enhancement in binding strength or specificity. The 
optimal conformation for the surface recognition or desired characteristics of the 
peptide could be obtained by modifying the repeating forms, as a way of 
multimerization [32].    
In this study, we have investigated the structural and the multimerazation effect on 
one of the strong Pt-binders, PTSTGQA. This peptide was previously identified from 
a random peptide phage display di-sulphite constrained library [30]. The second-
generation peptides were genetically designed as different number of repeats (two 
and three) in both constrained and linear forms. Structural and multimerization 
effects on the Pt-binding property of the peptide have been investigated. The peptide 
was first linearized from a disulfide-constrained structure by deleting two of the cysteine residues, 
then multiple repeat studies were carried out. Binding properties of the each second generated 
peptides have been evaluated by FM and ELISA analysis, and they were compared 
with the phage display selected first set of binder. 
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3.1. Linearization of Pt-binding Peptide 
Pt binding sequence SD152 was previously selected via 7 amino acid cyclic M13 
phage display library. To overcome possible limitation of the cyclic nature of the 
peptide, constraint SD152 was linearized, Cysteine residues on both sides of the 
peptide (Figure 3.1) were deleted one by one to construct the linear form as explained in 
Site directed mutagenesis studies section. 
 
g3p g3p
C 
C 
2nd C
1st C
 
 
 
C C PTSTGQA PTSTGQA
Figure 3.1. Constraint to linear conversion of SD152 
Cysteine residues on SD152 are called as 1st and 2nd C according to their 
localizations in N- or C- terminus of the peptide respectively (Figure 3.1). Firstly, 
one of the C residues, 2nd C, was deleted by using Invitrogen GeneTailor Site-
directed Mutagenesis Kit. Two overlapping primers namely; the forward 
(GTSD152d1C-F) primer contains the desired mutation which is the deletion of three 
bases coding cysteine amino acid and the reverse (GTSD152d1C-R) primer contains 
a 15- nucleotide sequence that is complementary to the forward primer and includes 
12 additional nucleotides at its 3` end were designed. Replicative form (dsDNA) of 
phage genome containing SD152 as a fusion in g3p was used as a template for 
mutagenesis reactions. dsDNA of SD152 was methylated by DNA methylase and the 
second cysteine residue was deleted by site-directed mutagenesis using PCR. The 
performance of mutagenesis PCR reaction was analyzed by agarose gel 
electrophoresis (Figure 3.2). 
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 Figure 3.2. 2.5% agarose gel. M3: marker3, Lambda DNA / EcoRI+HindIII, PCR rxn: 
PCR product obtained from 2nd C mutagenesis reaction, SD152d2C: 2nd C deleted 
SD152 
Following the observation of desired DNA fragment on agarose gel, the extracted 
PCR product was transformed into bacterial host. Two different E. coli strains 
namely DH5α-T1 and DH5α-FT were used for transformation process. PCR product 
was transformed into E.coli DH5α-T1 CaCl2 competent cells. This strain provides 
the self-ligation of linear PCR product to form the circular phage DNA and digestion 
of methylated template leaving the mutated phage DNA generated during PCR. 
Mutated DNA obtained from PCR was seperated from unmutated template by 
DH5α-T1 cells, which have an endonuclase that digests methylated strands. 
However, E.coli DH5α-T1 doesn’t contain F pilus, which is required for phage 
infection. Therefore, mid-log E.coli DH5α-FT containing F pilus was added to 
transformation mixture during plating onto LB plates. Thereby, assembled phage 
containing the desired mutation released from transformation host was amplified in 
E.coli DH5α-FT.  
Blue-phage plaques observed on LB plate were amplified in E.coli DH5α-FT to 
obtain ssDNA for sequencing. However, it was impossible to obtain any ssDNA 
indicating that there was not any phage amplification, which designates to reduction 
or lost in phage viability. Phage infectivity can be affected with the unpaired C 
residue in the fused peptide. The unpaired C can constitute disulphide-bridge with 
any of the C residues in N1 or N2 domain of g3p resulting with unviable phage. In 
the case of SD152, unpaired C residue obtained after mutagenesis reaction affected 
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the viability of phage. In the light of this assumption, two cysteine residues in 
peptide were deleted on the same template leaving out the interval phage 
amplification. 
                         
Figure 3.2. 2.5% agarose gel. M3: marker3, Lambda DNA / EcoRI+HindIII, circular 
SD152d2C: self-ligated 2nd C deleted SD152. 
PCR product of 2nd C mutagenesis reaction was extracted from the gel and purified 
to self-ligate by using T4 DNA ligase (Figure 3.3). Self-ligated template was 
methylated before applying the second mutagenesis reaction. The 1st C residue was 
deleted from the methylated template by using PCR and the gel picture of linearized 
SD152 was shown in Figure 3.2. 
  
Figure 3.2. 2.5% agarose gel. M3: marker3, Lambda DNA / EcoRI+HindIII, linear 
SD152: PCR product of 1st C deletion performed on self-ligated 2nd C deleted 
SD152. 
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The PCR product was transformed into E. coli DH5α-T1 competent cells. 
Transformation mixture was plated onto LB plate with mid-log E. coli DH5α-FT cell 
culture required for phage amplification.  
Each blue-phage plaque observed on LB plate was picked up with a pipette tip and 
put into PC buffer containing wells of an Elisa plate to obtain storage plates. Phage 
solutions in storage plates were inoculated into mid-log E. coli DH5α-FT cell culture 
in liquid media for amplification. Single stranded phage DNA was purified from 
amplified phages and used for sequence analysis. Sequencing results confirmed that 
the “linear SD152” was constructed.  
Glycerol stocks of newly constructed phage displaying linear SD152 were prepared 
and stored at –80oC.  
3.2. Multimerization of Pt-binding Peptide 
Multiple repeats of Pt-binding peptide SD152 were constructed both in constraint 
and linear form. Initially, constraint 3-repeat-SD152 was generated. Obtained 
constraint peptide was linearized by deleting cysteine residues via site-directed 
mutagenesis. 2-repeat-SD152 was constructed in a linear form containing one 
cysteine residue. Constraint and linear forms of 2-repeat-SD152 were generated via 
inserting and deleting the other cysteine residue respectively.  
3.2.1. Construction of Multiple Repeating Peptide in Constraint Form  
M13KE is an M13 derivative, which contains Acc65I and EagI restriction sites 
located into 5’ end of gene III. Thus, peptides cloned into, displayed on minor coat 
protein as N-terminal fusions. Because M13KE is a phage vector, the cloned peptide 
will be displayed on all 5 copies of g3p on the surface of the phage. This type of 
polyvalent display allows comparing binding affinities of different peptides. Since, 
peptides longer than generally 30 amino acids might have a deleterious effect on 
phage infectivity; display of short peptides is offered. Also the short peptides offer 
the flexibility to take part in as fusion product into many other functional proteins. 
Here, we constructed three repeat constraint peptide displayed on M13KE minor coat 
protein. To achieve this, 3-repeat-SD152 oligonucleotide was synthesized in such a 
way that 3 repeat peptide contains two cysteines on both ends; a glycine rich linker in 
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C-terminus of the peptide and restriction enzyme recognition sites (Figure 3.3). 
Thereby, disulfide-constraint three repeat peptide would be inserted into N-terminus 
of g3p with a linker region between the peptide and g3p. Synthesized oligonucleotide 
was converted to double stranded form by using Klenow fragment and run on 2.5% 
agarose gel to confirm the fragment length (Figure 3.4).  
             Extension primer 
 5’ CATGCCCGGGTACCTTTCTATTCTC   3’ 
            3’ GGGCCCATGGAAAGATAAGAGTGAGACGAACA [PP TT SS TT GG QQ AA ]3 33
ACGCCACCTCCAAGCCGGCTTTGTAC 5’         
               Oligonucleotide 
Figure 3.3. Annealing of three repeat SD152 oligonucleotide with the extension 
primer. Peptide sequence is written in orange, cysteine residues are in red, glycine 
rich linker sequence is in blue and restriction enzyme recognition sites are 
underlined.  
 
Figure 3.4. Extended duplex run on 12% PAGE (Polyacrylamide gel) with weight 
markers M9 and M10. Exact fragment length of 121 bp can be observed on gel.  
In the first step extended duplex was cloned into a pDrive-cloning vector. Because of 
pDrive is a TA cloning vector, requires unpaired Adenine residues on 3’ ends of 
insert DNA to be ligated. However, klenow fragment doesn’t add adenine residues to 
3’ ends of DNA. Therefore, before cloning, unpaired Adenine bases were added to 3’ 
ends of the extended duplex. By using this vector, we could easily control whether 
the three repeat sequence was constructed without any mutation and the positive 
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clones were easily checked through sequencing and then they were amplified to get 
the  required amount of insert for ligation into phage vector. 
pDrive vector with 3-repeat-SD152 insertion was amplified and digested with EagI 
and Acc65I restriction enzymes. Three DNA fragments, which are 59 bp, 104 bp and 
163 bp in length, were obtained after digestion. Digestion mixture was run on 2.5% 
agarose gel and desired 104 bp fragment which belongs to 3 repeat-SD152 was 
extracted (Figure 3.5.) 
 
Figure 3.5. A. 2.5% agarose gel; DNA fragments obtained after EagI and Acc65I 
digestion of pDrive containing 3-repeat-SD152, B. 12% PAGE (Polyacrylamide gel); 
3-repeat-SD152 after gel extraction. 
 
Figure 3.6.  1% agarose gel; linear M13KE phage vector obtained after EagI and 
Acc65I restriction.  
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Cleaned and concentrated insert DNA was ligated into M13KE vector digested 
(Figure 3.6.) with the same restriction enzymes. Ligation product was transformed 
into E. coli. ER2738 electro-competent cell, which is the efficient host for phage 
amplification. Blue-phage plaques observed on LB plate were amplified and ssDNA 
of phage particles were purified.  
Construction of phage-displayed “constraint 3 repeat-SD152” was confirmed via 
sequence analysis of single stranded phage DNA.    
3.2.2. Linearization of Multiple Repeat SD152  
Conversion of constraint 3 repeat-SD152 to linear form was achieved by deleting the 
C residues. Initially 2nd C residue was deleted. To perform the deletion, two primers 
were designed in such a way that both leading the construction of three repeat and 
two repeat of the peptides. When Reverse primer binds to the 3rd repeating unit 
(coloured blue in figure 3.7) linearized form of 3 repeat-SD152 is constructed. In the 
case of 2 repeat-SD152, Reverse primer binds to 2nd repeating unit (coloured yellow 
in figure 3.7) initiating the extension of 2 repeat-SD152 in linear form. Primer 
binding sites yielding three and two repeat SD152 are given in Figure 3.7.  
 
Figure 3.7. Primer binding sites are shown in 2nd C deletion reaction. Multiple units 
of 3 repeat-SD152 are written in different colors, blue, yellow and green. Deleting 
cysteine is written as an upper symbol. A. Annealing of primers resulting with the 
extension of three repeat SD152 B. Annealing of primers resulting with the extension 
of two repeat SD152 
Double stranded DNA of constrained 3-repeat-SD152 was used as a template to 
construct linearized form of three repeat and two repeat of SD152 in site directed 
mutagenesis reactions. Following the methylation of template DNA, mutagenesis 
reaction was applied as explained in site directed mutagenesis studies section. The 
obtained PCR product was visualized on an agarose gel electrophoresis as shown in 
Figure 3.8.  
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 Figure 3.8. 1% agarose gel. M3: marker3, Lambda DNA / EcoRI+HindIII, mrSD152 
d2C: PCR product of 2nd C deletion reaction performed on double stranded 
constraint 3 repeat-SD152. Obtained DNA fragment contains the double stranded 
multiple repeat (2 and 3) SD152 in which 2nd C was deleted.   
Unpaired cysteine residues in the fusion protein can interfere with phage viability. To 
overcome this problem, the other C residue was also deleted before transforming the 
mutagenesis reaction into bacterial host. 
The PCR product of 2nd C deletion was cleaned and self-ligated to obtain the 
template for the 1st C deletion reaction (this template was also used for 2-repeat-
SD152 construction in constraint form- in section 3.2.3.). Self-ligated template was 
methylated and mutated using the reverse and forward primers of GTSD152-d1C 
(Figure 3.9). 
 
Figure 3.9. 1% agarose gel. M3: marker3, Lambda DNA / EcoRI+HindIII, linear 
mrSD152: PCR product of 1st C deletion reaction performed on the self-ligated 
template coming from mtSD152-d2C. Obtained DNA fragment contains the double 
stranded multiple repeat (2 and 3) SD152 in linear form.   
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Mutagenesis reaction that will be giving the linear multiple repeat peptides are 
transformed into E. coli DH5α-T1 competent cells. While plating the transformation 
mixture, E. coli DH5α-FT cells, which are in mid-log phase, were added into the cell 
culture tube. DH5α-FT cells are crucial to provide the F pilus, which is required for 
phage infection and thus phage amplification.  
Each of all phage plaques observed on LB plate were picked up and transferred into 
the storage plates and then amplified in mid-log DH5α-FT culture in liquid media. 
ssDNA of phages were purified (Figure 3.10) to be sequenced. The results of 
sequencing confirmed that both 2 and 3 repeat of SD152 were obtained in linear 
form. 
 
Figure 3.10. 1% agarose gel. M3: marker3, Lambda DNA / EcoRI+HindIII, 1-10: 
DNA samples that were isolated from selected phage colonies 
3.2.3. Construction of Two repeat SD152 in Constraint Form 
There were two possible ways to obtain 2 –repeat-SD152 in constraint form. First 
one was to insert two of the C residues into the linear peptide that we have already 
constructed. However, in this situation we had to design two primers for each 
insertion mutagenesis. Thereby, we decided to apply the second way, which is to 
insert missing 2nd C into 2-repeat-SD152-d2C. Even though we don’t have the 
construct of 2-repeat-SD152-d2C, dsDNA encoding this peptide already existed in 
mutagenesis reaction obtained from 2nd C deletion of 3-repeat-SD152 (in section 
3.2.2.). On this account, PCR product of “2nd C deletion of 3-repeat-SD152” was 
cleaned and self-ligated.   
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 Figure 3.11. 1% agarose gel. M3: marker3, Lambda DNA / EcoRI+HindIII, 1: Self-
ligated mtSD152-d2C, 2: PCR product obtained from 2nd C insertion mutagenesis 
After methylation of self-ligated template, missing 2nd C was inserted using two 
primers namely GTSD152i2C-Forward and Reverse (Figure 3.11). Mutagenesis 
reaction was transformed into DH5α-T1 competent cells and phages were amplified 
in DH5α-FT cells. Sequence analysis of ssDNA purified from phage particles 
confirmed that 2-repeat-SD152 was constructed in linear form. 
3.3. Characterization of Second Generation Peptides 
Following site-directed mutagenesis of desired aminoacids, immunolabelling 
fluorescence microscopy (FM) and ELISA analysis’s of mutants were performed to 
compare the binding strength of the mutants to the wild type (identified via first 
generation of phage display libraries). Binding affinities of second generation 
peptides were  characterized through immunolabelling fluorescence microscopy 
(FM) and ELISA analysis to evaluate structure and multimerization effects of 
selected Pt binder SD152 peptide.  
3.3.1. Fluorescent Microscopy Analysis 
All the individual colonies were exposed to platinum powder. The mixture was 
rotated overnight and after washing the sample with PC buffer to remove unbound 
phage from the surface, anti-M13 g8p monoclonal antibody and Alexa-Fluor 
conjugated secondary antibody fragments were added to label the phage. The 
samples were visualized under fluorescence microscopy and the affinity of the 
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sequences was determined. Table 3.1 shows the second generation peptides 
characterized through fluorescent microscopy analysis and binding percentages of 
each peptide. 
Table 3.1. Second-generation SD152 peptides, their amino acid sequences and 
binding percentages are given 
Name Sequence Binding 
Percentage 
Constraint SD152 CPTSTGQAC % 10.45 
Linear SD152   PTSTGQA % 1 
Constraint 2 repeat SD152 CPTSTGQA PTSTGQA PTSTGQAC % 4 
Linear 2 repeat SD152    PTSTGQA PTSTGQA PTSTGQA % 1 
Constraint 3 repeat SD152 CPTSTGQA PTSTGQAC  % 8 
Linear 3 repeat SD152    PTSTGQA PTSTGQA  % 6 
Binding percentages of each peptide were determined with fluorescent microscopy 
images obtained from individual peptide. Binding affinities of second-generation 
peptides were compared with each other to follow the effect of structure and 
multimerization of peptides.    
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Linear SD152 linear
Constraint SD152  
 
Figure 3.12. Fluorescent and optical microscopy images of constraint and linear 
SD125. 
Figure 3.12 shows the fluorescent and optical microscopy images of constraint and 
linear SD152. Calculated binding percentages from these images indicated that while 
constraint SD152 has a binding affinity of nearly 10%, binding affinity of linear 
peptide is 1. This decrease in binding could be resulted from structure difference. 
Linear peptides can get multiple conformations enabling them to obtain optimal one 
for intermolecular interactions. In the case of SD152, linearization of the peptide 
resulted in a binding affinity reduction. In this specific conformation, constrained 
form possibly provided a condition for the peptide to expose its active site 
responsible for binding allowing the peptide to use these sites for the intermolecular 
interactions with the substrate. While this specific conformation occurs in a high 
energy level in unconstraint form, constraint peptide may obtain this conformation in 
a lower energy level, resulted in higher affinity. Thus, the optimal conformation for 
binding could be gained when the peptide is constraint.   
 55
In the next step, we examined the effects of multiple repeat on the platinum binding 
property via our developed protocol. Multiple repeat peptides were constructed both 
in linear and constraint form. Thus, the effect of multimerization was followed with 
respect different structural conformations as constrained and nonrestricted.  
 
Constrained 3 repeat SD152 
Constrained 2 repeat SD152 
Constraint SD152  
Figure 3.13. Fluorescent and optical microscopy images of multiple repeat SD152 
peptides in constraint form. 
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Fluorescent microscopy images and binding affinities of constraint multiple SD152 
peptides are given in Figure 3.13. Fluorescent microscopy analysis showed that 
binding affinity was reduced in multiple repeating. However, 3–repeat-SD152 has a 
higher binding affinity compared to 2-repeat-SD152 indicating that increasing the 
repeating unit, binding affinity can be increased.  
Linear SD152 linear
Linear 3 repeat SD152 
Linear 2 repeat SD152  
Figure 3.14. Fluorescent and optical microscopy images of multiple repeat SD152 
peptides in linear form. 
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Figure 3.14 is showing the fluorescent microscopy images and binding affinities of 
linear multiple SD152 peptides. Multimerization of peptide resulted in an increased 
binding affinity. When the repeating unit was increased from two to three, binding 
affinity was observed to be higher than the linear peptide.   
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Figure 3.15. Relative binding affinities of second-generation peptides  
Figure 3.15 shows the relative binding affinities of second-generation peptides to the 
phage library selected constraint SD152. 
In the next step, ELISA analyses were performed as an alternative method to 
characterize the affinity property of the second-generation peptides and their results 
were compared with the fluorescent microscopy analysis. 
3.3.2. ELISA Analysis 
All the individual colonies were exposed to platinum powder. The mixture was 
rotated 2 hours and washed the sample with PBS buffer to remove unbound phage 
from the surface. HRP-AntiM13 antibody conjugate was added to the mixture and 
after the incubation period washed several times to remove the unbound antibody. By 
adding TMP (the substrate of HRP) an enzymatic reaction was occurred resulting 
with change in the color from blue to yellow. The change in the color was measured 
at 450nm.  
ELISA analyses were performed for SD152 and 3-repeat-SD152 both in linear and 
constraint forms. Experiment was performed with different phage concentrations and 
in a triplet set for each concentration. Wild type M13KE was used as a blank in all 
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measurement. Figure 3.16 shows the results of ELISA experiment performed with 
109/μl of phage particles.  
   
Figure 3.16. The graph shows the measured absorbance degrees during ELISA 
analysis of constraint SD152, linear SD152, constraint 3-repeat-SD152 and linear 3-
repeat-SD152.  
ELISA analysis verified the data obtained from fluorescent microscopy analysis. 
Peptides tend to loose their affinity for the surface as they get a linear structure rather 
than constrained. However, increasing the repeating unit results in increasing their 
binding affinity even if they are in linear structure. Constraint peptides both in single 
and multiple repeated forms resulted in a high binding affinity comparing with the 
linear forms of the peptide.  
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4. CONCLUSION 
Second generation platinum binding peptides were genetically constructed on the 
filamentous M13 phage based on a phage display selected and well characterized 
one, SD152. This peptide is a 7-mer peptide in a disulphide constraint form with the 
amino sequence of PTSTGQA. Constraint SD152 has been characterized as a strong 
Pt binding peptide on the basis of varying characterization methods such as 
fluorescent microscopy analysis. 
Peptides were engineered to evaluate the effect of structural conformations and 
multimerization on the platinum affinity levels. Multimerization effects were 
investigated for single to three repeats of phage display selected platinum binding 
peptide. Constraint SD152 is first linearized. Than, 2 and 3 repeat peptides were 
constructed in constraint form as well as in linear form. 
In developing our engineering protocols for the second generation of peptides, we 
utilized different protein engineering tools such as site-directed and cassette 
mutagenesis. The mutagenesis techniques are widely used for the manipulation of 
plasmid vectors were adapted for engineering peptides displayed on filamentous 
phage in our study. Cassette mutagenesis techniques were used to construct multiple 
repeating peptides in constraint form. Constraint peptides were than linearized by 
deleting both cysteine residues one by one. 
Characterization experiments showed that the change in the structural property of 
peptides from constraint to linear resulted in a loss of the platinum affinity. However, 
the platinum affinity was increased with three repeat of the peptide in linear form.  
Our experiments indicated that binding affinity could be tuned up via genetic 
engineering approaches depending on the desired structure of the peptide for the 
controlled assembly processes. These novel engineering protocols will be of great 
utility for optimizing length or the molecular conformation of the inorganic specific 
peptides for controllable and predictable affinities. 
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APPENDIX 
Appendix A. 
Vector Map of M13KE 
Position (bp)  Element
6821- 831   gene II CDS (start 6821) 
496- 831        gene X CDS (start 496) 
843-1106        gene V CDS (start 843) 
1108-1209       gene VII CDS (start 1108) 
1206-1304       gene IX CDS (start 1206) 
1301-1522       gene VIII CDS (start 1301) 
1578-2852       gene III CDS (start 1578) 
2855-3193       gene VI CDS (start 2855) 
3195-4241       gene I CDS (start 3195) 
3915-4241       gene XI (gene I*) CDS (start 3915) 
4219-5499       gene IV CDS (start 4219) 
5487-5867       M13 origin of replication (- +) 
6216-6695       lacZ alpha CDS (start 6216) [74] 
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Appendix B. 
Vector Map of pDrive 
Position (bp)  Element
266–393  Multiple cloning site  
216–593  LacZ 〈-peptide  
239–258  T7 RNA polymerase promoter  
start 256  T7 transcription  
398–417  SP6 RNA polymerase promoter  
start 400  SP6 transcription  
1175–2032  Ampicillin resistance gene  
2181–2993  Kanamycin resistance gene  
3668     pUC origin  
588–1043  Phage f1 origin  
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 Appendix C. 
Molecular Weight Markers 
 
  a)      b)           c)   
 
 
a)  λ DNA EcoRI and HindIII digested marker-3, 1.0% agarose, 0.5µg/lane, 8 cm 
length  gel, 1X TAE, 17V/cm. (Catalog # SM0191, NBI Fermentas). 
b)  ΦX174 DNA BsuRI digested marker-9, 1.7% agarose, 0.5µg/lane, 8 cm length 
gel, 1X TBE, 5V/cm. (Catalog # SM0251, NBI Fermentas).  
c)  ΦX174 DNA HinfI digested marker-10, 2.5% agarose, 0.5µg/lane, 8 cm length 
gel, 1X TBE, 5V/cm. (Catalog # SM0261, NBI Fermentas). 
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 Appendix D. 
Lab Equipment 
Autoclaves       : 2540 ML benchtop autoclave, Systec GmbH 
Labor-Systemtechnik. 
: NuveOT 4060 vertical steam sterilizer, Nuve. 
Centrifuges      : Avanti J-30I, Beckman Coulter. 
: Microfuge 18, Beckman Coulter. 
Centrifuge rotors     : JA30.50Ti, Beckman Coulter. 
: F241.5P, Beckman Coulter. 
Deep freezes and refrigerators  : Heto Polar Bear 4410 ultra freezer, JOUAN 
Nordic A/S, catalog# 003431. 
: 2021 D deep freezer, Arcelik. 
: 1061 M refrigerator, Arcelik. 
Electrophoresis equipments  : E-C Mini Cell Primo EC320, E-C Apparatus. 
: Mini-PROTEAN 3 Cell and Single-Row 
 AnyGel Stand, Catalog# 165-3321,Bio-Rad. 
: Mini-V 8.10 Vertical Gel Electrophoresis 
System, Life Technologies GibcoBrl (now 
Invitrogen), Catalog# 21078. 
Gel documentation system   : UVIpro GAS7000, UVItec Limited. 
Ice Machine      : AF 10, Scotsman. 
Incubators       : EN400, Nuve. 
Orbital shaker      : Certomat S II, product# 886 252 4, B. Braun 
Biotech International GmbH. 
Magnetic stirrer     : AGE 10.0164, VELP Scientifica srl. 
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: ARE 10.0162, VELP Scientifica srl. 
Microscope                  : BX60, Olympus Corporation. 
: CH60, Olympus Corporation. 
Microscope Camera    : RT Slider, Spot Diagnostic Instruments. 
Pipettes       : Pipetteman P10, P 100, P1000, Eppendorf 
pH meter       : MP 220, Mettler Toledo International Inc. 
: Inolab pH level 1, order# 1A10-1113, 
Wissenschaftlich-Technische Werkstätten 
GmbH & Co KG. 
Power supply      : EC 250-90, E-C Apparatus. 
Pure water systems    : USF Elga UHQ-PS-MK3, Elga Labwater. 
Spectrophotometer    : DU530 Life Science UV/ Vis, Beckman. 
: UV-1601, Shimadzu Corporation. 
Sterilizer       : FN 500, Nuve. 
Transilluminator     : UV Transilluminator 2000, Catalog# 170- 
8110EDU, Bio- Rad. 
Vortexing machine     : Reax Top, product# 541-10000, Heidolph2.2. 
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 Appendix E. 
Color Coding of Amino acids 
Table A.1. Color Coding of Amino acids 
Hydrophobic A G V F P M I L W 
Acidic D E 
Basic R K 
Hydroxyl S T Y 
Amine+Basic H C N Q 
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